# CARGLUMIC ACID
> **ANDA213395** · Abbreviated New Drug Application (Generic) · Sponsor: NAVINTA LLC · Approved 2022-06-22
## Drug
- **FDA Application Number:** ANDA213395
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CARGLUMIC ACID
- **Generic name:** CARGLUMIC ACID
- **Active ingredients:** CARGLUMIC ACID
- **Dosage form:** TABLET, FOR SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** NAVINTA LLC
- **Manufacturer:** Navinta LLC
- **First approval:** 2022-06-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213395)
---
*AI Analytics · CC0 1.0*